Ajanta Pharma Limited has announced its schedule for an upcoming Analyst / Institutional Investor Meeting. The meeting is set to take place on June 17th & 18th, 2026. The company will be engaging in one-on-one discussions with Domestic Institutional Investors (DIIs) in Mumbai. Ajanta Pharma has confirmed that discussions will strictly adhere to previously published information.
Analyst / Institutional Investor Meeting
Ajanta Pharma Limited is pleased to announce the schedule for an upcoming Analyst / Institutional Investor Meeting. This important engagement is designed to facilitate discussions and provide updates to key stakeholders within the investment community.
Meeting Details
The meeting is scheduled to take place on June 17th and 18th, 2026. Ajanta Pharma will be hosting these sessions in Mumbai. The format of the meetings will be one-on-one discussions, specifically tailored for Domestic Institutional Investors (DIIs).
Information Disclosure
Ajanta Pharma wishes to confirm that all discussions during these meetings will be strictly based on information that has already been published. The company remains committed to transparency and maintaining an equitable flow of information to all market participants.
Schedule Flexibility
Please note that the schedule for these meetings is subject to change. Such modifications may occur due to unforeseen circumstances or exigencies on either side. Ajanta Pharma will endeavor to communicate any updates promptly should any changes arise.
Source: BSE
